Fingolimod - PDFSEARCH.IO - Document Search Engine

Fingolimod
Results: 83

#	Item
61	Managing Progressive MS M A NAGING M AJOR CH A NGES Rick (front cover), dignosed in[removed]Managing Progressive MS Add to Reading List Source URL: www.nationalmssociety.org Language: English - Date: 2014-03-20 10:18:47 Immune system Natalizumab Mitoxantrone Interferon beta-1a Fingolimod Interferon beta-1b Placebo Treatment of multiple sclerosis Pathophysiology of multiple sclerosis Multiple sclerosis Medicine Immunology
62	Initial REMS Approval: [removed]Most Recent Modification: [removed]NDA[removed]GILENYA® (fingolimod) 0.5mg capsules Add to Reading List Source URL: www.fda.gov Language: English Immunosuppressants Multiple sclerosis Diols Fingolimod Norfloxacin Methadone Ketorolac Chemistry Organic chemistry Piperazines
63	Latest advice for medicines users The monthly newsletter from the Medicines and Healthcare products Regulatory Agency and its independent advisor the Commission on Human Medicines Volume 5, Issue 7, February[removed]Conten Add to Reading List Source URL: www.mhra.gov.uk Language: English - Date: 2012-02-10 08:30:34 Multiple sclerosis Diols Fingolimod Immunosuppressants Immunology Yellow Card Scheme Adverse effect Allergy Pharmacovigilance Medicine Health Pharmacology
64	Resources for the Primary Care Provider Please print these out for reference Resources for providers American Academy of Neurology www.aan.com Add to Reading List Source URL: fcmcme.org Language: English - Date: 2012-05-21 20:25:23 Medicine Multiple sclerosis Immunosuppressants Autoimmune diseases Antivirals Interferon Glatiramer acetate Fingolimod Natalizumab Immunology Cytokines Immune system
65	INTRODUCTION It is a pleasure to present the annual report from The Danish Multiple Sclerosis Research Centre, Department of Neurology, Neuroscience Center Copenhagen University Hospital, Rigshospitalet. The Danish Multi Add to Reading List Source URL: www.ms-research.dk Language: English - Date: 2006-09-27 19:24:20 Multiple sclerosis Cytokines Immunosuppressants Glatiramer acetate Interferon beta-1a Natalizumab Interferon Biogen Idec Fingolimod Immunology Medicine Immune system
66	Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Autoimmune diseases Immunosuppressants Diols Fingolimod Treatment of multiple sclerosis Neuromyelitis optica Placebo Therapies under investigation for multiple sclerosis Medicine Multiple sclerosis Health
67	Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Medicine Multiple sclerosis Diols Fingolimod Biogen Idec Interferon beta-1a Natalizumab Serono Heart rate Immunology Immunosuppressants Pharmacology
68	Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Anatomy Natalizumab Tumefactive multiple sclerosis Fingolimod Magnetic resonance imaging Myelin Biogen Idec Demyelinating disease Pathophysiology of multiple sclerosis Multiple sclerosis Immunology Immune system
69	Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Immune system Multiple sclerosis Autoimmune diseases Natalizumab Cytokines Biogen Idec Progressive multifocal leukoencephalopathy JC virus Fingolimod Immunology Medicine Immunosuppressants
70	Clinical significance of serological biomarkers and neuropsychological performances in patients with temporal lobe epilepsy Add to Reading List Source URL: www.ncbi.nlm.nih.gov Language: English Medicine Immune system Expanded Disability Status Scale Treatment of multiple sclerosis Paced Auditory Serial Addition Test Glatiramer acetate Laquinimod Natalizumab Fingolimod Multiple sclerosis Immunology Immunosuppressants

UPDATE